Kathleen Sullivan to DiGeorge Syndrome
This is a "connection" page, showing publications Kathleen Sullivan has written about DiGeorge Syndrome.
Connection Strength
12.602
-
Bhattarai D, McGinn DE, Crowley TB, Giunta V, Gaiser K, Zackai EH, Emanuel BS, Heimall J, Jyonouchi S, Lee J, Sun D, McDonald-McGinn DM, Sullivan KE. Immunologic, Molecular, and Clinical Profile of Patients with Chromosome 22q11.2 Duplications. J Clin Immunol. 2023 05; 43(4):794-807.
Score: 0.863
-
Zhang Z, Shi L, Song L, Maurer K, Zhao X, Zackai EH, McGinn DE, Crowley TB, McGinn DMM, Sullivan KE. Chromatin Modifications in 22q11.2 Deletion Syndrome. J Clin Immunol. 2021 11; 41(8):1853-1864.
Score: 0.781
-
Crowley TB, Campbell IM, Liebling EJ, Lambert MP, Levitt Katz LE, Heimall J, Bailey A, McGinn DE, McDonald McGinn DM, Sullivan KE. Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases. J Allergy Clin Immunol. 2022 01; 149(1):445-450.
Score: 0.770
-
Dou Y, Blaine Crowley T, Gallagher S, Bailey A, McGinn D, Zackai E, Gur RE, McGinn DM, Sullivan KE. Increased T-cell counts in patients with 22q11.2 deletion syndrome who have anxiety. Am J Med Genet A. 2020 07; 182(7):1815-1818.
Score: 0.711
-
Sullivan KE. Immune Biomarkers of Autoimmunity in Chromosome 22q11.2 Deletion Syndrome. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2377-2378.
Score: 0.680
-
Sullivan KE. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Immunol Rev. 2019 01; 287(1):186-201.
Score: 0.650
-
Crowley B, Ruffner M, McDonald McGinn DM, Sullivan KE. Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome. Am J Med Genet A. 2018 10; 176(10):2082-2086.
Score: 0.608
-
Morsheimer M, Brown Whitehorn TF, Heimall J, Sullivan KE. The immune deficiency of chromosome 22q11.2 deletion syndrome. Am J Med Genet A. 2017 Sep; 173(9):2366-2372.
Score: 0.584
-
Sullivan KE, Burrows E, McDonald McGinn DM. Healthcare utilization in chromosome 22q11.2 deletion patients with cardiac disease and low T cell counts. Am J Med Genet A. 2016 06; 170(6):1630-4.
Score: 0.538
-
Derfalvi B, Maurer K, McDonald McGinn DM, Zackai E, Meng W, Luning Prak ET, Sullivan KE. B cell development in chromosome 22q11.2 deletion syndrome. Clin Immunol. 2016 Feb; 163:1-9.
Score: 0.526
-
Maggadottir SM, Sullivan KE. The diverse clinical features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome). J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):589-94.
Score: 0.452
-
Jawad AF, Prak EL, Boyer J, McDonald-McGinn DM, Zackai E, McDonald K, Sullivan KE. A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome). J Clin Immunol. 2011 Dec; 31(6):927-35.
Score: 0.390
-
McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011 Jan; 90(1):1-18.
Score: 0.373
-
Sullivan KE. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome. Immunol Allergy Clin North Am. 2008 May; 28(2):353-66.
Score: 0.310
-
Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007 Oct 20; 370(9596):1443-52.
Score: 0.299
-
Sullivan KE. DiGeorge syndrome/velocardiofacial syndrome: the chromosome 22q11.2 deletion syndrome. Adv Exp Med Biol. 2007; 601:37-49.
Score: 0.283
-
Cron RQ, Sullivan KE. Chronic arthritis without uveitis in velocardiofacial syndrome. J Pediatr. 2006 Aug; 149(2):281.
Score: 0.275
-
McDonald-McGinn DM, Reilly A, Wallgren-Pettersson C, Hoyme HE, Yang SP, Adam MP, Zackai EH, Sullivan KE. Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am J Med Genet A. 2006 Apr 15; 140(8):906-9.
Score: 0.269
-
Staple L, Andrews T, McDonald-McGinn D, Zackai E, Sullivan KE. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease. Pediatr Allergy Immunol. 2005 May; 16(3):226-30.
Score: 0.252
-
Sullivan KE. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol. 2004 Dec; 4(6):505-12.
Score: 0.245
-
Sullivan KE. Live viral vaccines in patients with DiGeorge syndrome. Clin Immunol. 2004 Oct; 113(1):3.
Score: 0.242
-
Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood. 2004 Feb 01; 103(3):1020-5.
Score: 0.226
-
Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Pediatrics. 2003 Oct; 112(4):e325.
Score: 0.226
-
Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr. 2003 Aug; 143(2):277-8.
Score: 0.223
-
Boot E, ?skarsd?ttir S, Loo JCY, Crowley TB, Orchanian-Cheff A, Andrade DM, Arganbright JM, Castelein RM, Cserti-Gazdewich C, de Reuver S, Fiksinski AM, Klingberg G, Lang AE, Mascarenhas MR, Moss EM, Nowakowska BA, Oechslin E, Palmer L, Repetto GM, Reyes NGD, Schneider M, Silversides C, Sullivan KE, Swillen A, van Amelsvoort TAMJ, Van Batavia JP, Vingerhoets C, McDonald-McGinn DM, Bassett AS. Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genet Med. 2023 03; 25(3):100344.
Score: 0.216
-
?skarsd?ttir S, Boot E, Crowley TB, Loo JCY, Arganbright JM, Armando M, Baylis AL, Breetvelt EJ, Castelein RM, Chadehumbe M, Cielo CM, de Reuver S, Eliez S, Fiksinski AM, Forbes BJ, Gallagher E, Hopkins SE, Jackson OA, Levitz-Katz L, Klingberg G, Lambert MP, Marino B, Mascarenhas MR, Moldenhauer J, Moss EM, Nowakowska BA, Orchanian-Cheff A, Putotto C, Repetto GM, Schindewolf E, Schneider M, Solot CB, Sullivan KE, Swillen A, Unolt M, Van Batavia JP, Vingerhoets C, Vorstman J, Bassett AS, McDonald-McGinn DM. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 03; 25(3):100338.
Score: 0.216
-
Mustillo PJ, Sullivan KE, Chinn IK, Notarangelo LD, Haddad E, Davies EG, de la Morena MT, Hartog N, Yu JE, Hernandez-Trujillo VP, Ip W, Franco J, Gambineri E, Hickey SE, Varga E, Markert ML. Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 02; 43(2):247-270.
Score: 0.215
-
Crowley TB, McGinn DM, Sullivan KE. 22q11.2 Deletion and Duplication Syndromes and COVID-19. J Clin Immunol. 2022 05; 42(4):746-748.
Score: 0.203
-
Deshpande DR, Demirdag YY, Marsh RA, Sullivan KE, Orange JS. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study. J Clin Immunol. 2021 01; 41(1):29-37.
Score: 0.183
-
Campbell IM, Sheppard SE, Crowley TB, McGinn DE, Bailey A, McGinn MJ, Unolt M, Homans JF, Chen EY, Salmons HI, Gaynor JW, Goldmuntz E, Jackson OA, Katz LE, Mascarenhas MR, Deeney VFX, Castelein RM, Zur KB, Elden L, Kallish S, Kolon TF, Hopkins SE, Chadehumbe MA, Lambert MP, Forbes BJ, Moldenhauer JS, Schindewolf EM, Solot CB, Moss EM, Gur RE, Sullivan KE, Emanuel BS, Zackai EH, McDonald-McGinn DM. What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. Am J Med Genet A. 2018 10; 176(10):2058-2069.
Score: 0.160
-
Benn P, Iyengar S, Crowley TB, Zackai EH, Burrows EK, Moshkevich S, McDonald-McGinn DM, Sullivan KE, Demko Z. Pediatric healthcare costs for patients with 22q11.2 deletion syndrome. Mol Genet Genomic Med. 2017 11; 5(6):631-638.
Score: 0.148
-
Barry JC, Crowley TB, Jyonouchi S, Heimall J, Zackai EH, Sullivan KE, McDonald-McGinn DM. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency. J Clin Immunol. 2017 Jul; 37(5):476-485.
Score: 0.145
-
McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE, Scambler PJ, Bassett AS. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015 11 19; 1:15071.
Score: 0.131
-
McDonald-McGinn DM, Fahiminiya S, Revil T, Nowakowska BA, Suhl J, Bailey A, Mlynarski E, Lynch DR, Yan AC, Bilaniuk LT, Sullivan KE, Warren ST, Emanuel BS, Vermeesch JR, Zackai EH, Jerome-Majewska LA. Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J Med Genet. 2013 Feb; 50(2):80-90.
Score: 0.107
-
Patel K, Akhter J, Kobrynski L, Benjamin Gathmann MA, Gathman B, Davis O, Sullivan KE. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. J Pediatr. 2012 Nov; 161(5):950-3.
Score: 0.104